Stephen Krieger, MD, Talks Ocrelizumab in RRMS and PPMS Treatment
May 25th 2017Stephen Krieger, MD, an associate professor at Mount Sinai Hospital, discusses the impact that recently-approved drug ocrelizumab has on the state of multiple sclerosis care, as well as his patient-centered app that depicts the MS condition in a more accurate manner, at the 2017 Consortium of Multiple Sclerosis Centers in New Orleans.
Read More
The Hidden Role of Testosterone in Multiple Sclerosis
May 24th 2017Clyde Markowitz, MD, director of the MS Center at the University of Pennsylvania, discusses how the patterns of male-to-female ratio in MS diagnoses may be linked to hormones, and whether testosterone could be key in bettering treatment.
Read More
Interdisciplinary, Patient-centered, Comprehensive Care Necessary for MS Treatment
May 24th 2017At CMSC 2017, Aaron Boster, MD, neuroimmunologist for OhioHealth Neurological Clinicians, discussed why he believes there's never been a better time of opportunity for multiple sclerosis patients, and what must be improved in MS diagnosis practice.
Read More